5 Stocks With Robust Sales Growth to Overcome Macro Challenges

Key Takeaways Sales growth is highlighted as a stronger gauge than earnings in volatile market conditions.Universal Health, Methanex, Arista, Voya and Maximus are screened for robust sales growth.Arista leads with projected 25.4% 2025 sales growth, while Voya follows with 16.1%.Markets started 2025 on a positive note but have since faced considerable volatility. Tariff-related headwinds and geopolitical uncertainty persist, yet the Federal Reserve’s interest rate cut signals a softening labor market and the ...